Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Supply, Demand and Key Producers, 2026-2032
The global Long-Acting Implant & Ocular Drug-Delivery Polymer System market size is expected to reach $ 4086 million by 2032, rising at a market growth of 6.4% CAGR during the forecast period (2026-2032).
A Long-Acting Implant & Ocular Drug-Delivery Polymer System is an advanced drug delivery platform that utilizes biodegradable or non-biodegradable polymer materials as carriers to provide sustained and controlled release of small molecules, biologics, or gene-based therapeutics directly to intraocular or periocular target sites. These systems are typically designed as implants, microspheres, microneedle-based depots, sustained-release films, or scaffolds capable of maintaining therapeutic drug concentrations for extended periods, thereby reducing the frequency of repeated intravitreal injections and improving patient adherence. Core technologies involve polymer degradation kinetics control, drug encapsulation efficiency, release profile modulation, biocompatibility optimization, and precision localization. This field represents a convergence of materials science, pharmaceutical engineering, and unmet clinical needs in ophthalmology. In 2025, global Long-Acting Implant & Ocular Drug-Delivery Polymer System production reached approximately 513.6 K Units and price is about 5000 USD/Unit. The average gross profit margin of this product is 55%.
Ophthalmic disease management is shifting from acute intervention to long-term chronic control, particularly in conditions such as age-related macular degeneration, diabetic retinopathy, and uveitis. The burden associated with frequent intravitreal injections has accelerated demand for sustained-release polymer systems capable of extending dosing intervals while maintaining therapeutic consistency. Advances in biodegradable polymers such as PLA, PLGA, and PCL, combined with the widespread adoption of biologics and anti-VEGF therapies, have reinforced the strategic importance of controlled release technologies. Regulatory acceptance of innovative delivery platforms further supports the establishment of differentiated product portfolios.
Key challenges include stringent biocompatibility requirements, lengthy safety validation processes, and complex clinical endpoints. Implant-based systems may present risks such as inflammatory responses or burst release, requiring highly controlled material purity and manufacturing consistency. Development costs are significant due to the dual demands of advanced materials engineering and sterile pharmaceutical production. Market penetration may also depend on physician training, procedural familiarity, and reimbursement policies for novel delivery approaches.
Clinical demand is evolving toward sustained therapeutic maintenance rather than repeated acute injections. Specialty ophthalmic centers and ambulatory surgical facilities increasingly favor solutions that reduce follow-up frequency and optimize clinical workflow efficiency. Patients prioritize safety and quality-of-life improvements. Future development trends point toward combination platforms integrating long-acting polymer systems with biologics, gene therapies, or anti-inflammatory agents to enable personalized, long-term treatment strategies.
Upstream inputs primarily include biodegradable polymers such as PLGA, PLA, and PCL, medical-grade silicone or polyurethane materials, high-purity solvents, crosslinking agents, and encapsulation excipients. Polymer molecular weight distribution and degradation kinetics directly influence release profile stability, necessitating stringent quality control and batch consistency. Sterile processing environments, precision molding, and microfabrication technologies are foundational capabilities. As smart-responsive and tunable degradation materials evolve, upstream suppliers with strong customization and collaborative innovation capacity are becoming increasingly strategic within the value chain.
This report studies the global Long-Acting Implant & Ocular Drug-Delivery Polymer System production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Long-Acting Implant & Ocular Drug-Delivery Polymer System and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Long-Acting Implant & Ocular Drug-Delivery Polymer System that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Long-Acting Implant & Ocular Drug-Delivery Polymer System total production and demand, 2021-2032, (K Units)
Global Long-Acting Implant & Ocular Drug-Delivery Polymer System total production value, 2021-2032, (USD Million)
Global Long-Acting Implant & Ocular Drug-Delivery Polymer System production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Long-Acting Implant & Ocular Drug-Delivery Polymer System consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Long-Acting Implant & Ocular Drug-Delivery Polymer System domestic production, consumption, key domestic manufacturers and share
Global Long-Acting Implant & Ocular Drug-Delivery Polymer System production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Long-Acting Implant & Ocular Drug-Delivery Polymer System production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Long-Acting Implant & Ocular Drug-Delivery Polymer System production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Long-Acting Implant & Ocular Drug-Delivery Polymer System market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Alcon, Johnson & Johnson, Bausch + Lomb, EyePoint Pharmaceuticals, Regeneron Pharmaceuticals, Santen Pharmaceutical, Allergan (AbbVie), Alimera Sciences, Ocular Therapeutix, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Long-Acting Implant & Ocular Drug-Delivery Polymer System market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Market, By Region:
1. How big is the global Long-Acting Implant & Ocular Drug-Delivery Polymer System market?
2. What is the demand of the global Long-Acting Implant & Ocular Drug-Delivery Polymer System market?
3. What is the year over year growth of the global Long-Acting Implant & Ocular Drug-Delivery Polymer System market?
4. What is the production and production value of the global Long-Acting Implant & Ocular Drug-Delivery Polymer System market?
5. Who are the key producers in the global Long-Acting Implant & Ocular Drug-Delivery Polymer System market?
6. What are the growth factors driving the market demand?
A Long-Acting Implant & Ocular Drug-Delivery Polymer System is an advanced drug delivery platform that utilizes biodegradable or non-biodegradable polymer materials as carriers to provide sustained and controlled release of small molecules, biologics, or gene-based therapeutics directly to intraocular or periocular target sites. These systems are typically designed as implants, microspheres, microneedle-based depots, sustained-release films, or scaffolds capable of maintaining therapeutic drug concentrations for extended periods, thereby reducing the frequency of repeated intravitreal injections and improving patient adherence. Core technologies involve polymer degradation kinetics control, drug encapsulation efficiency, release profile modulation, biocompatibility optimization, and precision localization. This field represents a convergence of materials science, pharmaceutical engineering, and unmet clinical needs in ophthalmology. In 2025, global Long-Acting Implant & Ocular Drug-Delivery Polymer System production reached approximately 513.6 K Units and price is about 5000 USD/Unit. The average gross profit margin of this product is 55%.
Ophthalmic disease management is shifting from acute intervention to long-term chronic control, particularly in conditions such as age-related macular degeneration, diabetic retinopathy, and uveitis. The burden associated with frequent intravitreal injections has accelerated demand for sustained-release polymer systems capable of extending dosing intervals while maintaining therapeutic consistency. Advances in biodegradable polymers such as PLA, PLGA, and PCL, combined with the widespread adoption of biologics and anti-VEGF therapies, have reinforced the strategic importance of controlled release technologies. Regulatory acceptance of innovative delivery platforms further supports the establishment of differentiated product portfolios.
Key challenges include stringent biocompatibility requirements, lengthy safety validation processes, and complex clinical endpoints. Implant-based systems may present risks such as inflammatory responses or burst release, requiring highly controlled material purity and manufacturing consistency. Development costs are significant due to the dual demands of advanced materials engineering and sterile pharmaceutical production. Market penetration may also depend on physician training, procedural familiarity, and reimbursement policies for novel delivery approaches.
Clinical demand is evolving toward sustained therapeutic maintenance rather than repeated acute injections. Specialty ophthalmic centers and ambulatory surgical facilities increasingly favor solutions that reduce follow-up frequency and optimize clinical workflow efficiency. Patients prioritize safety and quality-of-life improvements. Future development trends point toward combination platforms integrating long-acting polymer systems with biologics, gene therapies, or anti-inflammatory agents to enable personalized, long-term treatment strategies.
Upstream inputs primarily include biodegradable polymers such as PLGA, PLA, and PCL, medical-grade silicone or polyurethane materials, high-purity solvents, crosslinking agents, and encapsulation excipients. Polymer molecular weight distribution and degradation kinetics directly influence release profile stability, necessitating stringent quality control and batch consistency. Sterile processing environments, precision molding, and microfabrication technologies are foundational capabilities. As smart-responsive and tunable degradation materials evolve, upstream suppliers with strong customization and collaborative innovation capacity are becoming increasingly strategic within the value chain.
This report studies the global Long-Acting Implant & Ocular Drug-Delivery Polymer System production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Long-Acting Implant & Ocular Drug-Delivery Polymer System and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Long-Acting Implant & Ocular Drug-Delivery Polymer System that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Long-Acting Implant & Ocular Drug-Delivery Polymer System total production and demand, 2021-2032, (K Units)
Global Long-Acting Implant & Ocular Drug-Delivery Polymer System total production value, 2021-2032, (USD Million)
Global Long-Acting Implant & Ocular Drug-Delivery Polymer System production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Long-Acting Implant & Ocular Drug-Delivery Polymer System consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Long-Acting Implant & Ocular Drug-Delivery Polymer System domestic production, consumption, key domestic manufacturers and share
Global Long-Acting Implant & Ocular Drug-Delivery Polymer System production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Long-Acting Implant & Ocular Drug-Delivery Polymer System production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Long-Acting Implant & Ocular Drug-Delivery Polymer System production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Long-Acting Implant & Ocular Drug-Delivery Polymer System market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Alcon, Johnson & Johnson, Bausch + Lomb, EyePoint Pharmaceuticals, Regeneron Pharmaceuticals, Santen Pharmaceutical, Allergan (AbbVie), Alimera Sciences, Ocular Therapeutix, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Long-Acting Implant & Ocular Drug-Delivery Polymer System market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Subcutaneous and Intramuscular Implants
- Intravitreal and Ocular Implants
- Oncology and Chronic Pain
- Ophthalmology
- Endocrine and Women's Health
- Other
- Biodegradable
- Non-Degradable
- Hospital
- Dental Clinic
- Other
- Novartis
- Alcon
- Johnson & Johnson
- Bausch + Lomb
- EyePoint Pharmaceuticals
- Regeneron Pharmaceuticals
- Santen Pharmaceutical
- Allergan (AbbVie)
- Alimera Sciences
- Ocular Therapeutix
- Graybug Vision
- Aerie Pharmaceuticals
- Neurotech Pharmaceuticals
- Teva Pharmaceutical Industries
- Sun Pharmaceutical Industries
- EyeGate Pharmaceuticals
- PolyActiva
- EyeD Pharma
- Ripple Therapeutics
- Re?Vana Therapeutics
1. How big is the global Long-Acting Implant & Ocular Drug-Delivery Polymer System market?
2. What is the demand of the global Long-Acting Implant & Ocular Drug-Delivery Polymer System market?
3. What is the year over year growth of the global Long-Acting Implant & Ocular Drug-Delivery Polymer System market?
4. What is the production and production value of the global Long-Acting Implant & Ocular Drug-Delivery Polymer System market?
5. Who are the key producers in the global Long-Acting Implant & Ocular Drug-Delivery Polymer System market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Long-Acting Implant & Ocular Drug-Delivery Polymer System Introduction
1.2 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Supply & Forecast
1.2.1 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value (2021 & 2025 & 2032)
1.2.2 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (2021-2032)
1.2.3 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Pricing Trends (2021-2032)
1.3 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production by Region (Based on Production Site)
1.3.1 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value by Region (2021-2032)
1.3.2 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production by Region (2021-2032)
1.3.3 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Average Price by Region (2021-2032)
1.3.4 North America Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (2021-2032)
1.3.5 Europe Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (2021-2032)
1.3.6 China Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (2021-2032)
1.3.7 Japan Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Long-Acting Implant & Ocular Drug-Delivery Polymer System Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Long-Acting Implant & Ocular Drug-Delivery Polymer System Major Market Trends
2 DEMAND SUMMARY
2.1 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Demand (2021-2032)
2.2 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption by Region
2.2.1 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption by Region (2021-2026)
2.2.2 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption Forecast by Region (2027-2032)
2.3 United States Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption (2021-2032)
2.4 China Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption (2021-2032)
2.5 Europe Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption (2021-2032)
2.6 Japan Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption (2021-2032)
2.7 South Korea Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption (2021-2032)
2.8 ASEAN Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption (2021-2032)
2.9 India Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value by Manufacturer (2021-2026)
3.2 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production by Manufacturer (2021-2026)
3.3 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Average Price by Manufacturer (2021-2026)
3.4 Long-Acting Implant & Ocular Drug-Delivery Polymer System Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Long-Acting Implant & Ocular Drug-Delivery Polymer System in 2025
3.5.3 Global Concentration Ratios (CR8) for Long-Acting Implant & Ocular Drug-Delivery Polymer System in 2025
3.6 Long-Acting Implant & Ocular Drug-Delivery Polymer System Market: Overall Company Footprint Analysis
3.6.1 Long-Acting Implant & Ocular Drug-Delivery Polymer System Market: Region Footprint
3.6.2 Long-Acting Implant & Ocular Drug-Delivery Polymer System Market: Company Product Type Footprint
3.6.3 Long-Acting Implant & Ocular Drug-Delivery Polymer System Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value Comparison
4.1.1 United States VS China: Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Comparison
4.2.1 United States VS China: Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption Comparison
4.3.1 United States VS China: Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value (2021-2026)
4.4.3 United States Based Manufacturers Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (2021-2026)
4.5 China Based Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturers and Market Share
4.5.1 China Based Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value (2021-2026)
4.5.3 China Based Manufacturers Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (2021-2026)
4.6 Rest of World Based Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Subcutaneous and Intramuscular Implants
5.2.2 Intravitreal and Ocular Implants
5.3 Market Segment by Type
5.3.1 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production by Type (2021-2032)
5.3.2 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value by Type (2021-2032)
5.3.3 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY DISEASE
6.1 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Market Size Overview by Disease: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Disease
6.2.1 Oncology and Chronic Pain
6.2.2 Ophthalmology
6.2.3 Endocrine and Women's Health
6.2.4 Other
6.3 Market Segment by Disease
6.3.1 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production by Disease (2021-2032)
6.3.2 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value by Disease (2021-2032)
6.3.3 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Average Price by Disease (2021-2032)
7 MARKET ANALYSIS BY POLYMER TYPE
7.1 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Market Size Overview by Polymer Type: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Polymer Type
7.2.1 Biodegradable
7.2.2 Non-Degradable
7.3 Market Segment by Polymer Type
7.3.1 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production by Polymer Type (2021-2032)
7.3.2 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value by Polymer Type (2021-2032)
7.3.3 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Average Price by Polymer Type (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospital
8.2.2 Dental Clinic
8.2.3 Other
8.3 Market Segment by Application
8.3.1 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production by Application (2021-2032)
8.3.2 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value by Application (2021-2032)
8.3.3 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Novartis
9.1.1 Novartis Details
9.1.2 Novartis Major Business
9.1.3 Novartis Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
9.1.4 Novartis Long-Acting Implant & Ocular Drug-Delivery Polymer System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Novartis Recent Developments/Updates
9.1.6 Novartis Competitive Strengths & Weaknesses
9.2 Alcon
9.2.1 Alcon Details
9.2.2 Alcon Major Business
9.2.3 Alcon Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
9.2.4 Alcon Long-Acting Implant & Ocular Drug-Delivery Polymer System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Alcon Recent Developments/Updates
9.2.6 Alcon Competitive Strengths & Weaknesses
9.3 Johnson & Johnson
9.3.1 Johnson & Johnson Details
9.3.2 Johnson & Johnson Major Business
9.3.3 Johnson & Johnson Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
9.3.4 Johnson & Johnson Long-Acting Implant & Ocular Drug-Delivery Polymer System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Johnson & Johnson Recent Developments/Updates
9.3.6 Johnson & Johnson Competitive Strengths & Weaknesses
9.4 Bausch + Lomb
9.4.1 Bausch + Lomb Details
9.4.2 Bausch + Lomb Major Business
9.4.3 Bausch + Lomb Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
9.4.4 Bausch + Lomb Long-Acting Implant & Ocular Drug-Delivery Polymer System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Bausch + Lomb Recent Developments/Updates
9.4.6 Bausch + Lomb Competitive Strengths & Weaknesses
9.5 EyePoint Pharmaceuticals
9.5.1 EyePoint Pharmaceuticals Details
9.5.2 EyePoint Pharmaceuticals Major Business
9.5.3 EyePoint Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
9.5.4 EyePoint Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 EyePoint Pharmaceuticals Recent Developments/Updates
9.5.6 EyePoint Pharmaceuticals Competitive Strengths & Weaknesses
9.6 Regeneron Pharmaceuticals
9.6.1 Regeneron Pharmaceuticals Details
9.6.2 Regeneron Pharmaceuticals Major Business
9.6.3 Regeneron Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
9.6.4 Regeneron Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Regeneron Pharmaceuticals Recent Developments/Updates
9.6.6 Regeneron Pharmaceuticals Competitive Strengths & Weaknesses
9.7 Santen Pharmaceutical
9.7.1 Santen Pharmaceutical Details
9.7.2 Santen Pharmaceutical Major Business
9.7.3 Santen Pharmaceutical Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
9.7.4 Santen Pharmaceutical Long-Acting Implant & Ocular Drug-Delivery Polymer System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Santen Pharmaceutical Recent Developments/Updates
9.7.6 Santen Pharmaceutical Competitive Strengths & Weaknesses
9.8 Allergan (AbbVie)
9.8.1 Allergan (AbbVie) Details
9.8.2 Allergan (AbbVie) Major Business
9.8.3 Allergan (AbbVie) Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
9.8.4 Allergan (AbbVie) Long-Acting Implant & Ocular Drug-Delivery Polymer System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Allergan (AbbVie) Recent Developments/Updates
9.8.6 Allergan (AbbVie) Competitive Strengths & Weaknesses
9.9 Alimera Sciences
9.9.1 Alimera Sciences Details
9.9.2 Alimera Sciences Major Business
9.9.3 Alimera Sciences Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
9.9.4 Alimera Sciences Long-Acting Implant & Ocular Drug-Delivery Polymer System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Alimera Sciences Recent Developments/Updates
9.9.6 Alimera Sciences Competitive Strengths & Weaknesses
9.10 Ocular Therapeutix
9.10.1 Ocular Therapeutix Details
9.10.2 Ocular Therapeutix Major Business
9.10.3 Ocular Therapeutix Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
9.10.4 Ocular Therapeutix Long-Acting Implant & Ocular Drug-Delivery Polymer System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Ocular Therapeutix Recent Developments/Updates
9.10.6 Ocular Therapeutix Competitive Strengths & Weaknesses
9.11 Graybug Vision
9.11.1 Graybug Vision Details
9.11.2 Graybug Vision Major Business
9.11.3 Graybug Vision Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
9.11.4 Graybug Vision Long-Acting Implant & Ocular Drug-Delivery Polymer System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Graybug Vision Recent Developments/Updates
9.11.6 Graybug Vision Competitive Strengths & Weaknesses
9.12 Aerie Pharmaceuticals
9.12.1 Aerie Pharmaceuticals Details
9.12.2 Aerie Pharmaceuticals Major Business
9.12.3 Aerie Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
9.12.4 Aerie Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Aerie Pharmaceuticals Recent Developments/Updates
9.12.6 Aerie Pharmaceuticals Competitive Strengths & Weaknesses
9.13 Neurotech Pharmaceuticals
9.13.1 Neurotech Pharmaceuticals Details
9.13.2 Neurotech Pharmaceuticals Major Business
9.13.3 Neurotech Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
9.13.4 Neurotech Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 Neurotech Pharmaceuticals Recent Developments/Updates
9.13.6 Neurotech Pharmaceuticals Competitive Strengths & Weaknesses
9.14 Teva Pharmaceutical Industries
9.14.1 Teva Pharmaceutical Industries Details
9.14.2 Teva Pharmaceutical Industries Major Business
9.14.3 Teva Pharmaceutical Industries Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
9.14.4 Teva Pharmaceutical Industries Long-Acting Implant & Ocular Drug-Delivery Polymer System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 Teva Pharmaceutical Industries Recent Developments/Updates
9.14.6 Teva Pharmaceutical Industries Competitive Strengths & Weaknesses
9.15 Sun Pharmaceutical Industries
9.15.1 Sun Pharmaceutical Industries Details
9.15.2 Sun Pharmaceutical Industries Major Business
9.15.3 Sun Pharmaceutical Industries Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
9.15.4 Sun Pharmaceutical Industries Long-Acting Implant & Ocular Drug-Delivery Polymer System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 Sun Pharmaceutical Industries Recent Developments/Updates
9.15.6 Sun Pharmaceutical Industries Competitive Strengths & Weaknesses
9.16 EyeGate Pharmaceuticals
9.16.1 EyeGate Pharmaceuticals Details
9.16.2 EyeGate Pharmaceuticals Major Business
9.16.3 EyeGate Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
9.16.4 EyeGate Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.16.5 EyeGate Pharmaceuticals Recent Developments/Updates
9.16.6 EyeGate Pharmaceuticals Competitive Strengths & Weaknesses
9.17 PolyActiva
9.17.1 PolyActiva Details
9.17.2 PolyActiva Major Business
9.17.3 PolyActiva Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
9.17.4 PolyActiva Long-Acting Implant & Ocular Drug-Delivery Polymer System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.17.5 PolyActiva Recent Developments/Updates
9.17.6 PolyActiva Competitive Strengths & Weaknesses
9.18 EyeD Pharma
9.18.1 EyeD Pharma Details
9.18.2 EyeD Pharma Major Business
9.18.3 EyeD Pharma Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
9.18.4 EyeD Pharma Long-Acting Implant & Ocular Drug-Delivery Polymer System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.18.5 EyeD Pharma Recent Developments/Updates
9.18.6 EyeD Pharma Competitive Strengths & Weaknesses
9.19 Ripple Therapeutics
9.19.1 Ripple Therapeutics Details
9.19.2 Ripple Therapeutics Major Business
9.19.3 Ripple Therapeutics Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
9.19.4 Ripple Therapeutics Long-Acting Implant & Ocular Drug-Delivery Polymer System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.19.5 Ripple Therapeutics Recent Developments/Updates
9.19.6 Ripple Therapeutics Competitive Strengths & Weaknesses
9.20 Re?Vana Therapeutics
9.20.1 Re?Vana Therapeutics Details
9.20.2 Re?Vana Therapeutics Major Business
9.20.3 Re?Vana Therapeutics Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
9.20.4 Re?Vana Therapeutics Long-Acting Implant & Ocular Drug-Delivery Polymer System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.20.5 Re?Vana Therapeutics Recent Developments/Updates
9.20.6 Re?Vana Therapeutics Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Long-Acting Implant & Ocular Drug-Delivery Polymer System Industry Chain
10.2 Long-Acting Implant & Ocular Drug-Delivery Polymer System Upstream Analysis
10.2.1 Long-Acting Implant & Ocular Drug-Delivery Polymer System Core Raw Materials
10.2.2 Main Manufacturers of Long-Acting Implant & Ocular Drug-Delivery Polymer System Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Mode
10.6 Long-Acting Implant & Ocular Drug-Delivery Polymer System Procurement Model
10.7 Long-Acting Implant & Ocular Drug-Delivery Polymer System Industry Sales Model and Sales Channels
10.7.1 Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Model
10.7.2 Long-Acting Implant & Ocular Drug-Delivery Polymer System Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Long-Acting Implant & Ocular Drug-Delivery Polymer System Introduction
1.2 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Supply & Forecast
1.2.1 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value (2021 & 2025 & 2032)
1.2.2 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (2021-2032)
1.2.3 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Pricing Trends (2021-2032)
1.3 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production by Region (Based on Production Site)
1.3.1 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value by Region (2021-2032)
1.3.2 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production by Region (2021-2032)
1.3.3 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Average Price by Region (2021-2032)
1.3.4 North America Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (2021-2032)
1.3.5 Europe Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (2021-2032)
1.3.6 China Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (2021-2032)
1.3.7 Japan Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Long-Acting Implant & Ocular Drug-Delivery Polymer System Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Long-Acting Implant & Ocular Drug-Delivery Polymer System Major Market Trends
2 DEMAND SUMMARY
2.1 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Demand (2021-2032)
2.2 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption by Region
2.2.1 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption by Region (2021-2026)
2.2.2 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption Forecast by Region (2027-2032)
2.3 United States Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption (2021-2032)
2.4 China Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption (2021-2032)
2.5 Europe Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption (2021-2032)
2.6 Japan Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption (2021-2032)
2.7 South Korea Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption (2021-2032)
2.8 ASEAN Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption (2021-2032)
2.9 India Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value by Manufacturer (2021-2026)
3.2 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production by Manufacturer (2021-2026)
3.3 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Average Price by Manufacturer (2021-2026)
3.4 Long-Acting Implant & Ocular Drug-Delivery Polymer System Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Long-Acting Implant & Ocular Drug-Delivery Polymer System in 2025
3.5.3 Global Concentration Ratios (CR8) for Long-Acting Implant & Ocular Drug-Delivery Polymer System in 2025
3.6 Long-Acting Implant & Ocular Drug-Delivery Polymer System Market: Overall Company Footprint Analysis
3.6.1 Long-Acting Implant & Ocular Drug-Delivery Polymer System Market: Region Footprint
3.6.2 Long-Acting Implant & Ocular Drug-Delivery Polymer System Market: Company Product Type Footprint
3.6.3 Long-Acting Implant & Ocular Drug-Delivery Polymer System Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value Comparison
4.1.1 United States VS China: Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Comparison
4.2.1 United States VS China: Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption Comparison
4.3.1 United States VS China: Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value (2021-2026)
4.4.3 United States Based Manufacturers Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (2021-2026)
4.5 China Based Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturers and Market Share
4.5.1 China Based Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value (2021-2026)
4.5.3 China Based Manufacturers Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (2021-2026)
4.6 Rest of World Based Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Subcutaneous and Intramuscular Implants
5.2.2 Intravitreal and Ocular Implants
5.3 Market Segment by Type
5.3.1 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production by Type (2021-2032)
5.3.2 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value by Type (2021-2032)
5.3.3 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY DISEASE
6.1 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Market Size Overview by Disease: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Disease
6.2.1 Oncology and Chronic Pain
6.2.2 Ophthalmology
6.2.3 Endocrine and Women's Health
6.2.4 Other
6.3 Market Segment by Disease
6.3.1 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production by Disease (2021-2032)
6.3.2 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value by Disease (2021-2032)
6.3.3 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Average Price by Disease (2021-2032)
7 MARKET ANALYSIS BY POLYMER TYPE
7.1 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Market Size Overview by Polymer Type: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Polymer Type
7.2.1 Biodegradable
7.2.2 Non-Degradable
7.3 Market Segment by Polymer Type
7.3.1 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production by Polymer Type (2021-2032)
7.3.2 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value by Polymer Type (2021-2032)
7.3.3 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Average Price by Polymer Type (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospital
8.2.2 Dental Clinic
8.2.3 Other
8.3 Market Segment by Application
8.3.1 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production by Application (2021-2032)
8.3.2 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value by Application (2021-2032)
8.3.3 World Long-Acting Implant & Ocular Drug-Delivery Polymer System Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Novartis
9.1.1 Novartis Details
9.1.2 Novartis Major Business
9.1.3 Novartis Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
9.1.4 Novartis Long-Acting Implant & Ocular Drug-Delivery Polymer System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Novartis Recent Developments/Updates
9.1.6 Novartis Competitive Strengths & Weaknesses
9.2 Alcon
9.2.1 Alcon Details
9.2.2 Alcon Major Business
9.2.3 Alcon Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
9.2.4 Alcon Long-Acting Implant & Ocular Drug-Delivery Polymer System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Alcon Recent Developments/Updates
9.2.6 Alcon Competitive Strengths & Weaknesses
9.3 Johnson & Johnson
9.3.1 Johnson & Johnson Details
9.3.2 Johnson & Johnson Major Business
9.3.3 Johnson & Johnson Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
9.3.4 Johnson & Johnson Long-Acting Implant & Ocular Drug-Delivery Polymer System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Johnson & Johnson Recent Developments/Updates
9.3.6 Johnson & Johnson Competitive Strengths & Weaknesses
9.4 Bausch + Lomb
9.4.1 Bausch + Lomb Details
9.4.2 Bausch + Lomb Major Business
9.4.3 Bausch + Lomb Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
9.4.4 Bausch + Lomb Long-Acting Implant & Ocular Drug-Delivery Polymer System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Bausch + Lomb Recent Developments/Updates
9.4.6 Bausch + Lomb Competitive Strengths & Weaknesses
9.5 EyePoint Pharmaceuticals
9.5.1 EyePoint Pharmaceuticals Details
9.5.2 EyePoint Pharmaceuticals Major Business
9.5.3 EyePoint Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
9.5.4 EyePoint Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 EyePoint Pharmaceuticals Recent Developments/Updates
9.5.6 EyePoint Pharmaceuticals Competitive Strengths & Weaknesses
9.6 Regeneron Pharmaceuticals
9.6.1 Regeneron Pharmaceuticals Details
9.6.2 Regeneron Pharmaceuticals Major Business
9.6.3 Regeneron Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
9.6.4 Regeneron Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Regeneron Pharmaceuticals Recent Developments/Updates
9.6.6 Regeneron Pharmaceuticals Competitive Strengths & Weaknesses
9.7 Santen Pharmaceutical
9.7.1 Santen Pharmaceutical Details
9.7.2 Santen Pharmaceutical Major Business
9.7.3 Santen Pharmaceutical Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
9.7.4 Santen Pharmaceutical Long-Acting Implant & Ocular Drug-Delivery Polymer System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Santen Pharmaceutical Recent Developments/Updates
9.7.6 Santen Pharmaceutical Competitive Strengths & Weaknesses
9.8 Allergan (AbbVie)
9.8.1 Allergan (AbbVie) Details
9.8.2 Allergan (AbbVie) Major Business
9.8.3 Allergan (AbbVie) Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
9.8.4 Allergan (AbbVie) Long-Acting Implant & Ocular Drug-Delivery Polymer System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Allergan (AbbVie) Recent Developments/Updates
9.8.6 Allergan (AbbVie) Competitive Strengths & Weaknesses
9.9 Alimera Sciences
9.9.1 Alimera Sciences Details
9.9.2 Alimera Sciences Major Business
9.9.3 Alimera Sciences Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
9.9.4 Alimera Sciences Long-Acting Implant & Ocular Drug-Delivery Polymer System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Alimera Sciences Recent Developments/Updates
9.9.6 Alimera Sciences Competitive Strengths & Weaknesses
9.10 Ocular Therapeutix
9.10.1 Ocular Therapeutix Details
9.10.2 Ocular Therapeutix Major Business
9.10.3 Ocular Therapeutix Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
9.10.4 Ocular Therapeutix Long-Acting Implant & Ocular Drug-Delivery Polymer System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Ocular Therapeutix Recent Developments/Updates
9.10.6 Ocular Therapeutix Competitive Strengths & Weaknesses
9.11 Graybug Vision
9.11.1 Graybug Vision Details
9.11.2 Graybug Vision Major Business
9.11.3 Graybug Vision Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
9.11.4 Graybug Vision Long-Acting Implant & Ocular Drug-Delivery Polymer System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Graybug Vision Recent Developments/Updates
9.11.6 Graybug Vision Competitive Strengths & Weaknesses
9.12 Aerie Pharmaceuticals
9.12.1 Aerie Pharmaceuticals Details
9.12.2 Aerie Pharmaceuticals Major Business
9.12.3 Aerie Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
9.12.4 Aerie Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Aerie Pharmaceuticals Recent Developments/Updates
9.12.6 Aerie Pharmaceuticals Competitive Strengths & Weaknesses
9.13 Neurotech Pharmaceuticals
9.13.1 Neurotech Pharmaceuticals Details
9.13.2 Neurotech Pharmaceuticals Major Business
9.13.3 Neurotech Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
9.13.4 Neurotech Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 Neurotech Pharmaceuticals Recent Developments/Updates
9.13.6 Neurotech Pharmaceuticals Competitive Strengths & Weaknesses
9.14 Teva Pharmaceutical Industries
9.14.1 Teva Pharmaceutical Industries Details
9.14.2 Teva Pharmaceutical Industries Major Business
9.14.3 Teva Pharmaceutical Industries Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
9.14.4 Teva Pharmaceutical Industries Long-Acting Implant & Ocular Drug-Delivery Polymer System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 Teva Pharmaceutical Industries Recent Developments/Updates
9.14.6 Teva Pharmaceutical Industries Competitive Strengths & Weaknesses
9.15 Sun Pharmaceutical Industries
9.15.1 Sun Pharmaceutical Industries Details
9.15.2 Sun Pharmaceutical Industries Major Business
9.15.3 Sun Pharmaceutical Industries Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
9.15.4 Sun Pharmaceutical Industries Long-Acting Implant & Ocular Drug-Delivery Polymer System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 Sun Pharmaceutical Industries Recent Developments/Updates
9.15.6 Sun Pharmaceutical Industries Competitive Strengths & Weaknesses
9.16 EyeGate Pharmaceuticals
9.16.1 EyeGate Pharmaceuticals Details
9.16.2 EyeGate Pharmaceuticals Major Business
9.16.3 EyeGate Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
9.16.4 EyeGate Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.16.5 EyeGate Pharmaceuticals Recent Developments/Updates
9.16.6 EyeGate Pharmaceuticals Competitive Strengths & Weaknesses
9.17 PolyActiva
9.17.1 PolyActiva Details
9.17.2 PolyActiva Major Business
9.17.3 PolyActiva Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
9.17.4 PolyActiva Long-Acting Implant & Ocular Drug-Delivery Polymer System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.17.5 PolyActiva Recent Developments/Updates
9.17.6 PolyActiva Competitive Strengths & Weaknesses
9.18 EyeD Pharma
9.18.1 EyeD Pharma Details
9.18.2 EyeD Pharma Major Business
9.18.3 EyeD Pharma Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
9.18.4 EyeD Pharma Long-Acting Implant & Ocular Drug-Delivery Polymer System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.18.5 EyeD Pharma Recent Developments/Updates
9.18.6 EyeD Pharma Competitive Strengths & Weaknesses
9.19 Ripple Therapeutics
9.19.1 Ripple Therapeutics Details
9.19.2 Ripple Therapeutics Major Business
9.19.3 Ripple Therapeutics Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
9.19.4 Ripple Therapeutics Long-Acting Implant & Ocular Drug-Delivery Polymer System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.19.5 Ripple Therapeutics Recent Developments/Updates
9.19.6 Ripple Therapeutics Competitive Strengths & Weaknesses
9.20 Re?Vana Therapeutics
9.20.1 Re?Vana Therapeutics Details
9.20.2 Re?Vana Therapeutics Major Business
9.20.3 Re?Vana Therapeutics Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
9.20.4 Re?Vana Therapeutics Long-Acting Implant & Ocular Drug-Delivery Polymer System Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.20.5 Re?Vana Therapeutics Recent Developments/Updates
9.20.6 Re?Vana Therapeutics Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Long-Acting Implant & Ocular Drug-Delivery Polymer System Industry Chain
10.2 Long-Acting Implant & Ocular Drug-Delivery Polymer System Upstream Analysis
10.2.1 Long-Acting Implant & Ocular Drug-Delivery Polymer System Core Raw Materials
10.2.2 Main Manufacturers of Long-Acting Implant & Ocular Drug-Delivery Polymer System Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Mode
10.6 Long-Acting Implant & Ocular Drug-Delivery Polymer System Procurement Model
10.7 Long-Acting Implant & Ocular Drug-Delivery Polymer System Industry Sales Model and Sales Channels
10.7.1 Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Model
10.7.2 Long-Acting Implant & Ocular Drug-Delivery Polymer System Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value by Region (2021-2026) & (USD Million)
Table 3. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value by Region (2027-2032) & (USD Million)
Table 4. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value Market Share by Region (2021-2026)
Table 5. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value Market Share by Region (2027-2032)
Table 6. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production by Region (2021-2026) & (K Units)
Table 7. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production by Region (2027-2032) & (K Units)
Table 8. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Market Share by Region (2021-2026)
Table 9. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Market Share by Region (2027-2032)
Table 10. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Long-Acting Implant & Ocular Drug-Delivery Polymer System Major Market Trends
Table 13. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption by Region (2021-2026) & (K Units)
Table 15. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Long-Acting Implant & Ocular Drug-Delivery Polymer System Producers in 2025
Table 18. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Long-Acting Implant & Ocular Drug-Delivery Polymer System Producers in 2025
Table 20. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Company Evaluation Quadrant
Table 22. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Site of Key Manufacturer
Table 24. Long-Acting Implant & Ocular Drug-Delivery Polymer System Market: Company Product Type Footprint
Table 25. Long-Acting Implant & Ocular Drug-Delivery Polymer System Market: Company Product Application Footprint
Table 26. Long-Acting Implant & Ocular Drug-Delivery Polymer System Competitive Factors
Table 27. Long-Acting Implant & Ocular Drug-Delivery Polymer System New Entrant and Capacity Expansion Plans
Table 28. Long-Acting Implant & Ocular Drug-Delivery Polymer System Mergers & Acquisitions Activity
Table 29. United States VS China Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Market Share (2021-2026)
Table 37. China Based Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Long-Acting Implant & Ocular Drug-Delivery Polymer System Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Market Share (2021-2026)
Table 42. Rest of World Based Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Long-Acting Implant & Ocular Drug-Delivery Polymer System Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Market Share (2021-2026)
Table 47. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production by Type (2021-2026) & (K Units)
Table 49. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production by Type (2027-2032) & (K Units)
Table 50. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value by Type (2021-2026) & (USD Million)
Table 51. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value by Type (2027-2032) & (USD Million)
Table 52. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value by Disease, (USD Million), 2021 & 2025 & 2032
Table 55. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production by Disease (2021-2026) & (K Units)
Table 56. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production by Disease (2027-2032) & (K Units)
Table 57. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value by Disease (2021-2026) & (USD Million)
Table 58. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value by Disease (2027-2032) & (USD Million)
Table 59. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Average Price by Disease (2021-2026) & (US$/Unit)
Table 60. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Average Price by Disease (2027-2032) & (US$/Unit)
Table 61. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value by Polymer Type, (USD Million), 2021 & 2025 & 2032
Table 62. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production by Polymer Type (2021-2026) & (K Units)
Table 63. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production by Polymer Type (2027-2032) & (K Units)
Table 64. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value by Polymer Type (2021-2026) & (USD Million)
Table 65. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value by Polymer Type (2027-2032) & (USD Million)
Table 66. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Average Price by Polymer Type (2021-2026) & (US$/Unit)
Table 67. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Average Price by Polymer Type (2027-2032) & (US$/Unit)
Table 68. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production by Application (2021-2026) & (K Units)
Table 70. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production by Application (2027-2032) & (K Units)
Table 71. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value by Application (2021-2026) & (USD Million)
Table 72. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value by Application (2027-2032) & (USD Million)
Table 73. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Average Price by Application (2027-2032) & (US$/Unit)
Table 75. Novartis Basic Information, Manufacturing Base and Competitors
Table 76. Novartis Major Business
Table 77. Novartis Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
Table 78. Novartis Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Novartis Recent Developments/Updates
Table 80. Novartis Competitive Strengths & Weaknesses
Table 81. Alcon Basic Information, Manufacturing Base and Competitors
Table 82. Alcon Major Business
Table 83. Alcon Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
Table 84. Alcon Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Alcon Recent Developments/Updates
Table 86. Alcon Competitive Strengths & Weaknesses
Table 87. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 88. Johnson & Johnson Major Business
Table 89. Johnson & Johnson Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
Table 90. Johnson & Johnson Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Johnson & Johnson Recent Developments/Updates
Table 92. Johnson & Johnson Competitive Strengths & Weaknesses
Table 93. Bausch + Lomb Basic Information, Manufacturing Base and Competitors
Table 94. Bausch + Lomb Major Business
Table 95. Bausch + Lomb Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
Table 96. Bausch + Lomb Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Bausch + Lomb Recent Developments/Updates
Table 98. Bausch + Lomb Competitive Strengths & Weaknesses
Table 99. EyePoint Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 100. EyePoint Pharmaceuticals Major Business
Table 101. EyePoint Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
Table 102. EyePoint Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. EyePoint Pharmaceuticals Recent Developments/Updates
Table 104. EyePoint Pharmaceuticals Competitive Strengths & Weaknesses
Table 105. Regeneron Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 106. Regeneron Pharmaceuticals Major Business
Table 107. Regeneron Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
Table 108. Regeneron Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Regeneron Pharmaceuticals Recent Developments/Updates
Table 110. Regeneron Pharmaceuticals Competitive Strengths & Weaknesses
Table 111. Santen Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 112. Santen Pharmaceutical Major Business
Table 113. Santen Pharmaceutical Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
Table 114. Santen Pharmaceutical Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Santen Pharmaceutical Recent Developments/Updates
Table 116. Santen Pharmaceutical Competitive Strengths & Weaknesses
Table 117. Allergan (AbbVie) Basic Information, Manufacturing Base and Competitors
Table 118. Allergan (AbbVie) Major Business
Table 119. Allergan (AbbVie) Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
Table 120. Allergan (AbbVie) Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Allergan (AbbVie) Recent Developments/Updates
Table 122. Allergan (AbbVie) Competitive Strengths & Weaknesses
Table 123. Alimera Sciences Basic Information, Manufacturing Base and Competitors
Table 124. Alimera Sciences Major Business
Table 125. Alimera Sciences Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
Table 126. Alimera Sciences Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Alimera Sciences Recent Developments/Updates
Table 128. Alimera Sciences Competitive Strengths & Weaknesses
Table 129. Ocular Therapeutix Basic Information, Manufacturing Base and Competitors
Table 130. Ocular Therapeutix Major Business
Table 131. Ocular Therapeutix Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
Table 132. Ocular Therapeutix Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Ocular Therapeutix Recent Developments/Updates
Table 134. Ocular Therapeutix Competitive Strengths & Weaknesses
Table 135. Graybug Vision Basic Information, Manufacturing Base and Competitors
Table 136. Graybug Vision Major Business
Table 137. Graybug Vision Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
Table 138. Graybug Vision Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Graybug Vision Recent Developments/Updates
Table 140. Graybug Vision Competitive Strengths & Weaknesses
Table 141. Aerie Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 142. Aerie Pharmaceuticals Major Business
Table 143. Aerie Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
Table 144. Aerie Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Aerie Pharmaceuticals Recent Developments/Updates
Table 146. Aerie Pharmaceuticals Competitive Strengths & Weaknesses
Table 147. Neurotech Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 148. Neurotech Pharmaceuticals Major Business
Table 149. Neurotech Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
Table 150. Neurotech Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. Neurotech Pharmaceuticals Recent Developments/Updates
Table 152. Neurotech Pharmaceuticals Competitive Strengths & Weaknesses
Table 153. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 154. Teva Pharmaceutical Industries Major Business
Table 155. Teva Pharmaceutical Industries Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
Table 156. Teva Pharmaceutical Industries Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. Teva Pharmaceutical Industries Recent Developments/Updates
Table 158. Teva Pharmaceutical Industries Competitive Strengths & Weaknesses
Table 159. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 160. Sun Pharmaceutical Industries Major Business
Table 161. Sun Pharmaceutical Industries Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
Table 162. Sun Pharmaceutical Industries Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. Sun Pharmaceutical Industries Recent Developments/Updates
Table 164. Sun Pharmaceutical Industries Competitive Strengths & Weaknesses
Table 165. EyeGate Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 166. EyeGate Pharmaceuticals Major Business
Table 167. EyeGate Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
Table 168. EyeGate Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 169. EyeGate Pharmaceuticals Recent Developments/Updates
Table 170. EyeGate Pharmaceuticals Competitive Strengths & Weaknesses
Table 171. PolyActiva Basic Information, Manufacturing Base and Competitors
Table 172. PolyActiva Major Business
Table 173. PolyActiva Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
Table 174. PolyActiva Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. PolyActiva Recent Developments/Updates
Table 176. PolyActiva Competitive Strengths & Weaknesses
Table 177. EyeD Pharma Basic Information, Manufacturing Base and Competitors
Table 178. EyeD Pharma Major Business
Table 179. EyeD Pharma Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
Table 180. EyeD Pharma Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 181. EyeD Pharma Recent Developments/Updates
Table 182. EyeD Pharma Competitive Strengths & Weaknesses
Table 183. Ripple Therapeutics Basic Information, Manufacturing Base and Competitors
Table 184. Ripple Therapeutics Major Business
Table 185. Ripple Therapeutics Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
Table 186. Ripple Therapeutics Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 187. Ripple Therapeutics Recent Developments/Updates
Table 188. Ripple Therapeutics Competitive Strengths & Weaknesses
Table 189. Re?Vana Therapeutics Basic Information, Manufacturing Base and Competitors
Table 190. Re?Vana Therapeutics Major Business
Table 191. Re?Vana Therapeutics Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
Table 192. Re?Vana Therapeutics Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 193. Re?Vana Therapeutics Recent Developments/Updates
Table 194. Re?Vana Therapeutics Competitive Strengths & Weaknesses
Table 195. Global Key Players of Long-Acting Implant & Ocular Drug-Delivery Polymer System Upstream (Raw Materials)
Table 196. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Typical Customers
Table 197. Long-Acting Implant & Ocular Drug-Delivery Polymer System Typical Distributors
Table 1. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value by Region (2021-2026) & (USD Million)
Table 3. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value by Region (2027-2032) & (USD Million)
Table 4. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value Market Share by Region (2021-2026)
Table 5. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value Market Share by Region (2027-2032)
Table 6. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production by Region (2021-2026) & (K Units)
Table 7. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production by Region (2027-2032) & (K Units)
Table 8. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Market Share by Region (2021-2026)
Table 9. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Market Share by Region (2027-2032)
Table 10. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Long-Acting Implant & Ocular Drug-Delivery Polymer System Major Market Trends
Table 13. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption by Region (2021-2026) & (K Units)
Table 15. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Long-Acting Implant & Ocular Drug-Delivery Polymer System Producers in 2025
Table 18. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Long-Acting Implant & Ocular Drug-Delivery Polymer System Producers in 2025
Table 20. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Company Evaluation Quadrant
Table 22. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Site of Key Manufacturer
Table 24. Long-Acting Implant & Ocular Drug-Delivery Polymer System Market: Company Product Type Footprint
Table 25. Long-Acting Implant & Ocular Drug-Delivery Polymer System Market: Company Product Application Footprint
Table 26. Long-Acting Implant & Ocular Drug-Delivery Polymer System Competitive Factors
Table 27. Long-Acting Implant & Ocular Drug-Delivery Polymer System New Entrant and Capacity Expansion Plans
Table 28. Long-Acting Implant & Ocular Drug-Delivery Polymer System Mergers & Acquisitions Activity
Table 29. United States VS China Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Market Share (2021-2026)
Table 37. China Based Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Long-Acting Implant & Ocular Drug-Delivery Polymer System Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Market Share (2021-2026)
Table 42. Rest of World Based Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Long-Acting Implant & Ocular Drug-Delivery Polymer System Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Market Share (2021-2026)
Table 47. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production by Type (2021-2026) & (K Units)
Table 49. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production by Type (2027-2032) & (K Units)
Table 50. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value by Type (2021-2026) & (USD Million)
Table 51. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value by Type (2027-2032) & (USD Million)
Table 52. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value by Disease, (USD Million), 2021 & 2025 & 2032
Table 55. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production by Disease (2021-2026) & (K Units)
Table 56. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production by Disease (2027-2032) & (K Units)
Table 57. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value by Disease (2021-2026) & (USD Million)
Table 58. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value by Disease (2027-2032) & (USD Million)
Table 59. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Average Price by Disease (2021-2026) & (US$/Unit)
Table 60. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Average Price by Disease (2027-2032) & (US$/Unit)
Table 61. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value by Polymer Type, (USD Million), 2021 & 2025 & 2032
Table 62. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production by Polymer Type (2021-2026) & (K Units)
Table 63. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production by Polymer Type (2027-2032) & (K Units)
Table 64. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value by Polymer Type (2021-2026) & (USD Million)
Table 65. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value by Polymer Type (2027-2032) & (USD Million)
Table 66. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Average Price by Polymer Type (2021-2026) & (US$/Unit)
Table 67. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Average Price by Polymer Type (2027-2032) & (US$/Unit)
Table 68. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production by Application (2021-2026) & (K Units)
Table 70. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production by Application (2027-2032) & (K Units)
Table 71. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value by Application (2021-2026) & (USD Million)
Table 72. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value by Application (2027-2032) & (USD Million)
Table 73. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Average Price by Application (2027-2032) & (US$/Unit)
Table 75. Novartis Basic Information, Manufacturing Base and Competitors
Table 76. Novartis Major Business
Table 77. Novartis Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
Table 78. Novartis Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Novartis Recent Developments/Updates
Table 80. Novartis Competitive Strengths & Weaknesses
Table 81. Alcon Basic Information, Manufacturing Base and Competitors
Table 82. Alcon Major Business
Table 83. Alcon Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
Table 84. Alcon Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Alcon Recent Developments/Updates
Table 86. Alcon Competitive Strengths & Weaknesses
Table 87. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 88. Johnson & Johnson Major Business
Table 89. Johnson & Johnson Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
Table 90. Johnson & Johnson Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Johnson & Johnson Recent Developments/Updates
Table 92. Johnson & Johnson Competitive Strengths & Weaknesses
Table 93. Bausch + Lomb Basic Information, Manufacturing Base and Competitors
Table 94. Bausch + Lomb Major Business
Table 95. Bausch + Lomb Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
Table 96. Bausch + Lomb Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Bausch + Lomb Recent Developments/Updates
Table 98. Bausch + Lomb Competitive Strengths & Weaknesses
Table 99. EyePoint Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 100. EyePoint Pharmaceuticals Major Business
Table 101. EyePoint Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
Table 102. EyePoint Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. EyePoint Pharmaceuticals Recent Developments/Updates
Table 104. EyePoint Pharmaceuticals Competitive Strengths & Weaknesses
Table 105. Regeneron Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 106. Regeneron Pharmaceuticals Major Business
Table 107. Regeneron Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
Table 108. Regeneron Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Regeneron Pharmaceuticals Recent Developments/Updates
Table 110. Regeneron Pharmaceuticals Competitive Strengths & Weaknesses
Table 111. Santen Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 112. Santen Pharmaceutical Major Business
Table 113. Santen Pharmaceutical Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
Table 114. Santen Pharmaceutical Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Santen Pharmaceutical Recent Developments/Updates
Table 116. Santen Pharmaceutical Competitive Strengths & Weaknesses
Table 117. Allergan (AbbVie) Basic Information, Manufacturing Base and Competitors
Table 118. Allergan (AbbVie) Major Business
Table 119. Allergan (AbbVie) Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
Table 120. Allergan (AbbVie) Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Allergan (AbbVie) Recent Developments/Updates
Table 122. Allergan (AbbVie) Competitive Strengths & Weaknesses
Table 123. Alimera Sciences Basic Information, Manufacturing Base and Competitors
Table 124. Alimera Sciences Major Business
Table 125. Alimera Sciences Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
Table 126. Alimera Sciences Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Alimera Sciences Recent Developments/Updates
Table 128. Alimera Sciences Competitive Strengths & Weaknesses
Table 129. Ocular Therapeutix Basic Information, Manufacturing Base and Competitors
Table 130. Ocular Therapeutix Major Business
Table 131. Ocular Therapeutix Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
Table 132. Ocular Therapeutix Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Ocular Therapeutix Recent Developments/Updates
Table 134. Ocular Therapeutix Competitive Strengths & Weaknesses
Table 135. Graybug Vision Basic Information, Manufacturing Base and Competitors
Table 136. Graybug Vision Major Business
Table 137. Graybug Vision Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
Table 138. Graybug Vision Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Graybug Vision Recent Developments/Updates
Table 140. Graybug Vision Competitive Strengths & Weaknesses
Table 141. Aerie Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 142. Aerie Pharmaceuticals Major Business
Table 143. Aerie Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
Table 144. Aerie Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Aerie Pharmaceuticals Recent Developments/Updates
Table 146. Aerie Pharmaceuticals Competitive Strengths & Weaknesses
Table 147. Neurotech Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 148. Neurotech Pharmaceuticals Major Business
Table 149. Neurotech Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
Table 150. Neurotech Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. Neurotech Pharmaceuticals Recent Developments/Updates
Table 152. Neurotech Pharmaceuticals Competitive Strengths & Weaknesses
Table 153. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 154. Teva Pharmaceutical Industries Major Business
Table 155. Teva Pharmaceutical Industries Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
Table 156. Teva Pharmaceutical Industries Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. Teva Pharmaceutical Industries Recent Developments/Updates
Table 158. Teva Pharmaceutical Industries Competitive Strengths & Weaknesses
Table 159. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 160. Sun Pharmaceutical Industries Major Business
Table 161. Sun Pharmaceutical Industries Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
Table 162. Sun Pharmaceutical Industries Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. Sun Pharmaceutical Industries Recent Developments/Updates
Table 164. Sun Pharmaceutical Industries Competitive Strengths & Weaknesses
Table 165. EyeGate Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 166. EyeGate Pharmaceuticals Major Business
Table 167. EyeGate Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
Table 168. EyeGate Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 169. EyeGate Pharmaceuticals Recent Developments/Updates
Table 170. EyeGate Pharmaceuticals Competitive Strengths & Weaknesses
Table 171. PolyActiva Basic Information, Manufacturing Base and Competitors
Table 172. PolyActiva Major Business
Table 173. PolyActiva Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
Table 174. PolyActiva Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. PolyActiva Recent Developments/Updates
Table 176. PolyActiva Competitive Strengths & Weaknesses
Table 177. EyeD Pharma Basic Information, Manufacturing Base and Competitors
Table 178. EyeD Pharma Major Business
Table 179. EyeD Pharma Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
Table 180. EyeD Pharma Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 181. EyeD Pharma Recent Developments/Updates
Table 182. EyeD Pharma Competitive Strengths & Weaknesses
Table 183. Ripple Therapeutics Basic Information, Manufacturing Base and Competitors
Table 184. Ripple Therapeutics Major Business
Table 185. Ripple Therapeutics Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
Table 186. Ripple Therapeutics Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 187. Ripple Therapeutics Recent Developments/Updates
Table 188. Ripple Therapeutics Competitive Strengths & Weaknesses
Table 189. Re?Vana Therapeutics Basic Information, Manufacturing Base and Competitors
Table 190. Re?Vana Therapeutics Major Business
Table 191. Re?Vana Therapeutics Long-Acting Implant & Ocular Drug-Delivery Polymer System Product and Services
Table 192. Re?Vana Therapeutics Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 193. Re?Vana Therapeutics Recent Developments/Updates
Table 194. Re?Vana Therapeutics Competitive Strengths & Weaknesses
Table 195. Global Key Players of Long-Acting Implant & Ocular Drug-Delivery Polymer System Upstream (Raw Materials)
Table 196. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Typical Customers
Table 197. Long-Acting Implant & Ocular Drug-Delivery Polymer System Typical Distributors
LIST OF FIGURES
Figure 1. Long-Acting Implant & Ocular Drug-Delivery Polymer System Picture
Figure 2. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (2021-2032) & (K Units)
Figure 5. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Average Price (2021-2032) & (US$/Unit)
Figure 6. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value Market Share by Region (2021-2032)
Figure 7. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Market Share by Region (2021-2032)
Figure 8. North America Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (2021-2032) & (K Units)
Figure 9. Europe Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (2021-2032) & (K Units)
Figure 10. China Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (2021-2032) & (K Units)
Figure 11. Japan Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (2021-2032) & (K Units)
Figure 12. Long-Acting Implant & Ocular Drug-Delivery Polymer System Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption (2021-2032) & (K Units)
Figure 15. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption Market Share by Region (2021-2032)
Figure 16. United States Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption (2021-2032) & (K Units)
Figure 17. China Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption (2021-2032) & (K Units)
Figure 18. Europe Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption (2021-2032) & (K Units)
Figure 19. Japan Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption (2021-2032) & (K Units)
Figure 20. South Korea Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption (2021-2032) & (K Units)
Figure 21. ASEAN Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption (2021-2032) & (K Units)
Figure 22. India Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption (2021-2032) & (K Units)
Figure 23. Producer Shipments of Long-Acting Implant & Ocular Drug-Delivery Polymer System by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Long-Acting Implant & Ocular Drug-Delivery Polymer System Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Long-Acting Implant & Ocular Drug-Delivery Polymer System Markets in 2025
Figure 26. United States VS China: Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Market Share 2025
Figure 30. China Based Manufacturers Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Market Share 2025
Figure 32. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value Market Share by Type in 2025
Figure 34. Subcutaneous and Intramuscular Implants
Figure 35. Intravitreal and Ocular Implants
Figure 36. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Market Share by Type (2021-2032)
Figure 37. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value Market Share by Type (2021-2032)
Figure 38. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Average Price by Type (2021-2032) & (US$/Unit)
Figure 39. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value by Disease, (USD Million), 2021 & 2025 & 2032
Figure 40. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value Market Share by Disease in 2025
Figure 41. Oncology and Chronic Pain
Figure 42. Ophthalmology
Figure 43. Endocrine and Women's Health
Figure 44. Other
Figure 45. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Market Share by Disease (2021-2032)
Figure 46. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value Market Share by Disease (2021-2032)
Figure 47. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Average Price by Disease (2021-2032) & (US$/Unit)
Figure 48. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value by Polymer Type, (USD Million), 2021 & 2025 & 2032
Figure 49. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value Market Share by Polymer Type in 2025
Figure 50. Biodegradable
Figure 51. Non-Degradable
Figure 52. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Market Share by Polymer Type (2021-2032)
Figure 53. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value Market Share by Polymer Type (2021-2032)
Figure 54. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Average Price by Polymer Type (2021-2032) & (US$/Unit)
Figure 55. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 56. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value Market Share by Application in 2025
Figure 57. Hospital
Figure 58. Dental Clinic
Figure 59. Other
Figure 60. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Market Share by Application (2021-2032)
Figure 61. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value Market Share by Application (2021-2032)
Figure 62. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Average Price by Application (2021-2032) & (US$/Unit)
Figure 63. Long-Acting Implant & Ocular Drug-Delivery Polymer System Industry Chain
Figure 64. Long-Acting Implant & Ocular Drug-Delivery Polymer System Procurement Model
Figure 65. Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Model
Figure 66. Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Channels, Direct Sales, and Distribution
Figure 67. Methodology
Figure 68. Research Process and Data Source
Figure 1. Long-Acting Implant & Ocular Drug-Delivery Polymer System Picture
Figure 2. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (2021-2032) & (K Units)
Figure 5. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Average Price (2021-2032) & (US$/Unit)
Figure 6. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value Market Share by Region (2021-2032)
Figure 7. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Market Share by Region (2021-2032)
Figure 8. North America Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (2021-2032) & (K Units)
Figure 9. Europe Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (2021-2032) & (K Units)
Figure 10. China Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (2021-2032) & (K Units)
Figure 11. Japan Long-Acting Implant & Ocular Drug-Delivery Polymer System Production (2021-2032) & (K Units)
Figure 12. Long-Acting Implant & Ocular Drug-Delivery Polymer System Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption (2021-2032) & (K Units)
Figure 15. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption Market Share by Region (2021-2032)
Figure 16. United States Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption (2021-2032) & (K Units)
Figure 17. China Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption (2021-2032) & (K Units)
Figure 18. Europe Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption (2021-2032) & (K Units)
Figure 19. Japan Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption (2021-2032) & (K Units)
Figure 20. South Korea Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption (2021-2032) & (K Units)
Figure 21. ASEAN Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption (2021-2032) & (K Units)
Figure 22. India Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption (2021-2032) & (K Units)
Figure 23. Producer Shipments of Long-Acting Implant & Ocular Drug-Delivery Polymer System by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Long-Acting Implant & Ocular Drug-Delivery Polymer System Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Long-Acting Implant & Ocular Drug-Delivery Polymer System Markets in 2025
Figure 26. United States VS China: Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Market Share 2025
Figure 30. China Based Manufacturers Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Market Share 2025
Figure 32. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value Market Share by Type in 2025
Figure 34. Subcutaneous and Intramuscular Implants
Figure 35. Intravitreal and Ocular Implants
Figure 36. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Market Share by Type (2021-2032)
Figure 37. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value Market Share by Type (2021-2032)
Figure 38. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Average Price by Type (2021-2032) & (US$/Unit)
Figure 39. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value by Disease, (USD Million), 2021 & 2025 & 2032
Figure 40. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value Market Share by Disease in 2025
Figure 41. Oncology and Chronic Pain
Figure 42. Ophthalmology
Figure 43. Endocrine and Women's Health
Figure 44. Other
Figure 45. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Market Share by Disease (2021-2032)
Figure 46. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value Market Share by Disease (2021-2032)
Figure 47. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Average Price by Disease (2021-2032) & (US$/Unit)
Figure 48. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value by Polymer Type, (USD Million), 2021 & 2025 & 2032
Figure 49. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value Market Share by Polymer Type in 2025
Figure 50. Biodegradable
Figure 51. Non-Degradable
Figure 52. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Market Share by Polymer Type (2021-2032)
Figure 53. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value Market Share by Polymer Type (2021-2032)
Figure 54. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Average Price by Polymer Type (2021-2032) & (US$/Unit)
Figure 55. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 56. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value Market Share by Application in 2025
Figure 57. Hospital
Figure 58. Dental Clinic
Figure 59. Other
Figure 60. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Market Share by Application (2021-2032)
Figure 61. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Production Value Market Share by Application (2021-2032)
Figure 62. World Long-Acting Implant & Ocular Drug-Delivery Polymer System Average Price by Application (2021-2032) & (US$/Unit)
Figure 63. Long-Acting Implant & Ocular Drug-Delivery Polymer System Industry Chain
Figure 64. Long-Acting Implant & Ocular Drug-Delivery Polymer System Procurement Model
Figure 65. Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Model
Figure 66. Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Channels, Direct Sales, and Distribution
Figure 67. Methodology
Figure 68. Research Process and Data Source
